KELLY ROULEAU: Open Payments
NPI 1750510533 · PORTSMOUTH, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,513 in 129 payments from 16 companies in 2025. Trend: 2023 $3,100 · 2024 $3,235 · 2025 $2,513
Food & beverage: $2,513
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $458 |
| Regeneron Healthcare Solutions, Inc. | 10 | $422 |
| Organon LLC | 17 | $237 |
| Janssen Biotech, Inc. | 10 | $213 |
| Novartis Pharmaceuticals Corporation | 10 | $179 |
| Arcutis Biotherapeutics, Inc. | 13 | $154 |
| LEO Pharma Inc. | 10 | $144 |
| UCB, Inc. | 7 | $142 |
| GENZYME CORPORATION | 4 | $121 |
| Lilly USA, LLC | 5 | $118 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, Zoryve, Bimzelx, ADBRY, RINVOQ, OPZELURA.
Industry payments across NH — which companies pay providers there.
